Akebia Therapeutics Inc (NAS:AKBA)
$ 1.14 +0.10 (+10.14%) Market Cap: 305.81 Mil Enterprise Value: 194.19 Mil PE Ratio: 0 PB Ratio: 11.18 GF Score: 49/100

Akebia Therapeutics Inc (AKBA) Transcripts

  • 1